Skip to main content

Table 1 Characteristics of patients with active ocular toxoplasmosis

From: New findings useful for clinical practice using swept-source optical coherence tomography angiography in the follow-up of active ocular toxoplasmosis

Patient no., age, gender, study eye Symptom onseta Lesion location (zone) Lesion size (DD) BCVA at baseline BCVA at follow-up IgM IgG Clinical findings
1, 29 years, F, OD 20 days 1 2–3 Hand motion 20/125 NR R ACC 3+, IRH, VC 2+, IRL
2, 25 years, M, OS 15 days 2 1 20/20 20/20 NR R ACC1+, RNV, VC1+
3, 22 years, M, OS 1 day 1 < 1 20/60-2 20/25-1 NR R ACC 3+, KP, VC 1+, IRL, CNVM
4, 29 years, F, OD 15 days 1 < 1 20/160 20/120-1 R R ACC 3+, VC3+, IRL
5, 20 years, M, OD 4 days 1 < 1 20/25-2 20/20 NR R VC 2+
6, 31 years, F, OS 20 days 1 < 1 20/32 20/20 NR R ACC 1+, VC 2+
7, 20 years, F, OD 5 days 1 1–2 20/125 20/40 NR R ACC 3+, IRH, VC 1+
8, 15 years, F, OD 10 days 1 1–2 20/32-2 20/20 NR R ACC 1+, VC 1+
9, 40 years, M, OD 21 days 1 2–3 20/500 20/334 NR R ACC 3+, KP, VC 3+
10, 56 years, F, OS 6 days 1 < 1 Hand motion 20/30 NR R ACC 3+, KP, VC 2+
11, 41 years, F, OD 15 days 1 1–2 20/160 20/125 R R ACC 2+, VC 2+
12, 39 years, F, OD 5 days 1 1–2 20/100 20/32 NR R ACC 3+, VC1+
13, 28 years, M, OS 6 days 1 3 20/334 20/40 NR R ACC 3+, KP, VC 1+
14, 59 years, F, OS 15 days 1 > 6 DP 20/125 20/40 NR R ACC 3+, VC 2+
15, 32 years, M, OD 5 days 1 1–2 CF 1 m 20/100 R R ACC 2+, VC 1+
  1. DD disc diameter, BCVA best-corrected visual acuity, CF counting fingers, IgG toxoplasmosis immunoglobulin G, IgM toxoplasmosis immunoglobulin M, F female, M male, OD right eye, OS left eye, R reagent, NR non-reagent, ACC anterior chamber cells, VC vitreous cells, IRH intraretinal hemorrhage, RNV retinal neovascularization, KP keratic precipitates, CNVM choroidal neovascular membrane, IRL intraretinal loops
  2. aTime interval between symptom onset and baseline evaluation